A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)
about
The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.Effectiveness and safety profile of S-1-based chemotherapy compared with capecitabine-based chemotherapy for advanced gastric and colorectal cancer: A meta-analysis.Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis.S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study.Chemotherapy for advanced gastric cancer.Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.Bayesian population finding with biomarkers in a randomized clinical trial.
P2860
Q27318805-CF2D756F-4544-43D5-854E-0C9AEEAD11D4Q33415971-70594357-5630-4176-B5DA-7996CC72F512Q33889328-18101E44-794E-427F-A933-CCC26D73FE46Q35070531-DCABF621-4020-4027-BE28-429EAF78445FQ37644000-45B7AA00-B8DD-4DE7-90C3-D97E69A30130Q38604012-4C98F56C-1AE5-4AA2-9118-AA5593BE6630Q38645852-8B4E2942-CA0A-472D-88C9-CEF1F921B0A5Q38931091-5C8A5065-0505-4534-93F7-9C212A354BCC
P2860
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A randomized phase II trial to ...... ndomized PII trial (XParTS II)
@ast
A randomized phase II trial to ...... ndomized PII trial (XParTS II)
@en
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin
@nl
type
label
A randomized phase II trial to ...... ndomized PII trial (XParTS II)
@ast
A randomized phase II trial to ...... ndomized PII trial (XParTS II)
@en
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin
@nl
prefLabel
A randomized phase II trial to ...... ndomized PII trial (XParTS II)
@ast
A randomized phase II trial to ...... ndomized PII trial (XParTS II)
@en
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin
@nl
P2093
P2860
P356
P1433
P1476
A randomized phase II trial to ...... ndomized PII trial (XParTS II)
@en
P2093
Akira Tsuburaya
Jun-ichi Sakamoto
Kazuhiro Yoshida
Kensei Yamaguchi
Kohei Shitara
Michiya Kobayashi
Satoshi Morita
Shigefumi Yoshino
Takaki Yoshikawa
Yasuhiro Kodera
P2860
P2888
P356
10.1186/1471-2407-12-307
P407
P577
2012-07-23T00:00:00Z
P5875
P6179
1042338558